Yesterday we posted a guest column that raised questions about whether reseachers overstate the benefits of implantable heart devices known as implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.
Ultimately, that issue could influence the messages that patients receive.
A paper in the journal Health Expectations, “Patients’ decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death,” raises more questions about the messages patients receive concerning these devices.
In a small study, the researchers explored the decision-making process that took place among 44 patients. They report:
“Participants who experienced heart failure symptoms or non-life-threatening arrhythmic events (uncontrolled atrial arrhythmias) tended to (incorrectly) view the ICD as a possible treatment. Several were hopeful that the device would improve overall energy and ? or breathing difficulties. It was challenging for many participants who were experiencing symptoms to avoid associating the ICD with symptom relief, when the single- or dual-chamber ICDs were not intended for that purpose.
…
One could argue that the life-prolonging aspect of ICD therapy acts as a powerful influence towards acceptance of the device. However, patients may make sense of their personal risk depending on the manner in which the information is presented during medical consultations. Communication that includes statements about prolongation of life and statistical probabilities favouring survival is powerful and, as we discovered, influential when presented in isolation (without a balance of what to expect without the ICD). However, those seeking symptom relief from heart failure, acquiring information that delineates what a single- or dual-chamber ICD can and cannot deliver (i.e. symptom relief in the absence of cardiac resynchronization) could inform the decision-making process regardless of active or passive approach.
…
A preference for physicians to make final treatment choices was apparent among the majority of our participants. The alternative to not receiving an ICD did not surface as a focal point in conversations shared between our participants and physicians. These findings bring the question of informed consent to light. Do patients who adopt a passive approach truly comprehend what they are consenting or declining to? The alternative to not receiving an ICD may not be as appealing, in fact likely quite the opposite; however, treatment alternatives, especially in the context of existing comorbid health conditions, require discussion. What is more, the complexity of ICD technology demands a level of health literacy (that some patients may not have) also shown to influence health-related patient decision making, but that given the time or technique could be explained to patients’ satisfaction.”
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Lesley
June 17, 2011 at 1:04 amDear Gary, I refer you to an article in the NYtimes of June 18 2010
by Katy Butler, What Broke my Father’s Heart. A beautifully written account of a pace-maker, and the result of it’s insertion. I didn’t realise until reading the article that there are many kinds of pacemaker. The one inserted in this girl’s father’s heart lasted many years, when all he needed, was one to be inserted during a peri-operative period. I am from Australia, and have just joined this site. We have nothing like it over here, and it’s very timely.
Thank you.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like